financetom
Business
financetom
/
Business
/
BRIEF-Kestra Medical Technologies, Ltd. Announces Full Exercise And Closing Of Underwriters' Over-Allotment Option In Initial Public Offering
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Kestra Medical Technologies, Ltd. Announces Full Exercise And Closing Of Underwriters' Over-Allotment Option In Initial Public Offering
Mar 14, 2025 1:45 PM

March 14 (Reuters) - Kestra Medical Technologies Inc ( KMTS )

:

* KESTRA MEDICAL TECHNOLOGIES ( KMTS ), LTD. ANNOUNCES FULL EXERCISE

AND

CLOSING OF UNDERWRITERS' OVER-ALLOTMENT OPTION IN INITIAL PUBLIC

OFFERING

Source text:

Further company coverage:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Freedom Holding says Blackrock Has Increased Its Stake In Company To 0.85%, Investing About $89 Million
BRIEF-Freedom Holding says Blackrock Has Increased Its Stake In Company To 0.85%, Investing About $89 Million
Aug 31, 2025
Aug 31 (Reuters) - * BLACKROCK BECOMES THE SECOND-LARGEST SHAREHOLDER OF FREEDOM HOLDING CORP. * FREEDOM HOLDING CORP - BLACKROCK, INC. ( BLK ), HAS INCREASED ITS STAKE IN COMPANY TO 0.85%, INVESTING ABOUT $89 MILLION. Source text: Further company coverage: ...
CapVest nears $11.7 billion deal to acquire Stada, Bloomberg News reports
CapVest nears $11.7 billion deal to acquire Stada, Bloomberg News reports
Aug 31, 2025
Aug 31 (Reuters) - CapVest Partners is nearing a deal to acquire German drugmaker Stada Arzneimittel AG for about 10 billion euro ($11.7 billion) including debt, Bloomberg reported on Sunday, citing people familiar with the matter. The London-based buyout firm is finalizing terms of an agreement with Stada's private equity owners Bain Capital and Cinven, and a deal could be...
Novo Nordisk's Wegovy cuts heart risk by 57% versus rival Lilly weight-loss drug in study
Novo Nordisk's Wegovy cuts heart risk by 57% versus rival Lilly weight-loss drug in study
Aug 31, 2025
Aug 31 (Reuters) - Novo Nordisk said on Sunday its blockbuster weight-loss drug Wegovy cut the risk of heart attack, stroke or death by 57% versus Eli Lilly's ( LLY ) rival medicines Mounjaro and Zepbound in a real-world comparison of overweight and obese patients with cardiovascular disease but not diabetes. While this was not a randomized controlled trial, Novo...
US still working on trade deals despite court ruling, USTR says
US still working on trade deals despite court ruling, USTR says
Aug 31, 2025
WASHINGTON (Reuters) -The Trump administration is continuing its talks with trading partners despite a U.S. appeals court ruling that most of President Donald Trump's tariffs are illegal, U.S. Trade Representative Jamieson Greer said on Sunday. Our trading partners, they continue to work very closely with us on negotiations, he said in an interview on Fox News' Fox & Friends program....
Copyright 2023-2026 - www.financetom.com All Rights Reserved